CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596)
2018 ◽
Vol 10
(2)
◽
pp. 963-972
◽
2017 ◽
Vol 25
(suppl_1)
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. TPS4146-TPS4146
2011 ◽
Vol 132
(3)
◽
pp. 853-861
◽
2003 ◽
Vol 57
(2)
◽
pp. S215-S216
◽